Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients

Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients

Saved in:

Bibliographic Details
Main Authors:	Farheen Chunara, Chris Lugo, Kristen Osinski, Mansi R. Shah, Nishi Shah, Jessica Kent, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Gurbakhash Kaur, Rajshekhar Chakraborty, Rahul Banerjee, Leo Rasche, Carolina Schinke, Anita D’Souza, Aniko Szabo, Meera Mohan
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-025-01254-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
by: Carlyn Rose Tan, et al.
Published: (2025-07-01)

Manifestations of Teclistamab‐Associated Uveitis
by: Gabriel Castilho Barbosa, et al.
Published: (2025-06-01)

Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
by: Asis Shrestha, et al.
Published: (2025-04-01)

Perspectives on Talquetamab and its Utility in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
by: Miller KC, et al.
Published: (2025-04-01)

Teclistamab for heavily pretreated relapsed / refractory POEMS syndrome
by: Alexis Talbot, et al.
Published: (2025-07-01)

Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
by: Danai Dima, et al.
Published: (2025-07-01)

Injection site reaction to teclistamab in a patient with multiple myeloma
by: Isabel C. Yoon, BS, et al.
Published: (2025-02-01)

D609 Suppresses Antituberculosis Response by Regulating Dendritic Cells Antigen Presentation
by: Honglin Liu, et al.
Published: (2024-12-01)

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma
by: Meera Mohan, et al.
Published: (2025-04-01)

MONITORAMENTO DOS EFEITOS ADVERSOS DO TECLISTAMABE: PAPEL DA ENFERMAGEM
by: VMS Moraes, et al.
Published: (2024-10-01)

GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series
by: Murali Janakiram, et al.
Published: (2025-08-01)

Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma
by: Renata Quevedo‐Salazar, et al.
Published: (2025-06-01)

Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
by: James A. Davis, et al.
Published: (2025-03-01)

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
by: Charles Pei, et al.
Published: (2025-08-01)

Total Internal Reflection End-Pumped Solar Laser with the Solar-to-Laser Conversion Efficiency of 6.09%
by: Lin Wang, et al.
Published: (2025-07-01)

Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis
by: Wenze Li, et al.
Published: (2025-04-01)

P609: Mainstreaming genetics: Evaluation of a digital application to scale and spread oncologist-initiated genetic testing
by: Daniel Assamad, et al.
Published: (2025-01-01)

Molecular epidemiological study of exosomes circZNF609, circPUM1, IGF2 with ischemic stroke
by: Suhai Fei, et al.
Published: (2025-03-01)

WCN24-609 ASSOCIATION BETWEEN URIC ACID LEVELS WITH CHRONIC KIDNEY DISEASE, GENERAL AND CARDIOVASCULAR MORTALITY
by: Alfonso Rafael Alvarez Paredes, et al.
Published: (2024-04-01)

Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesResearch in context
by: Darshi Shah, et al.
Published: (2025-08-01)

Anti-antioxidant impacts of circZNF609 silence in HaCaT cells through regulating miR-145
by: Rongli Ge, et al.
Published: (2020-01-01)

Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab
by: Deena Mudawi, et al.
Published: (2025-05-01)

Chicken CircZNF609 encodes a protein induced by IRES-like region that inhibits the proliferation and promotes the differentiation of myoblasts
by: Lei Li, et al.
Published: (2025-08-01)

Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
by: Oren Pasvolsky, et al.
Published: (2025-05-01)

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study
by: Carlyn Rose Tan, et al.
Published: (2025-04-01)

اسلامی تعلیم اور دعوتِ دین میں فنُونِ لطیفہ کا استعمال (افادیت اور اصول وضوابط)
by: Zobia Kousar, et al.
Published: (2021-06-01)

Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
by: Danai Dima, et al.
Published: (2025-06-01)

WCN25-1014 TECLISTAMAB AND NIVOLUMAB: A SYNERGISTIC KIDNEY STORM - A CASE OF ACUTE INTERSTITIAL NEPHRITIS WITH DUAL IMMUNOTHERAPY
by: Arjunmohan Mohan, et al.
Published: (2025-02-01)

Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab
by: Erin A. Dean, et al.
Published: (2025-08-01)

Markus Schiegg. 2022. Flexible Schreiber in der Sprachgeschichte. Intraindividuelle Variation in Patientenbriefen (1850–1936) (Germanistische Bibliothek 75). Heidelberg: Universitätsverlag Winter. 609 S.
by: Rössler Paul
Published: (2024-11-01)

Effect of Beneficial Colonization of Bacillus coagulans NRS 609 on Growth Performance, Intestinal Health, Antioxidant Capacity, and Immune Response of Common Carp (Cyprinus carpio L.)
by: Jianxin Zhang, et al.
Published: (2023-01-01)

Combined Methylmalonic Aciduria and Homocystinuria cblC Type of a Taiwanese Infant With c.609G>A and c.567dupT Mutations in the MMACHC Gene
by: Jenn-Tzong Chang, et al.
Published: (2011-08-01)

Proceso de atención de enfermería aplicado a paciente post embolizado por hemorragia subaracnoidea I60.9, un estudio de caso
by: Ruth Marilyn Arias Francia, et al.
Published: (2023-08-01)

Quaking–cZFP609 Axis Remedies Aberrant Plasticity of Vascular Smooth Muscle Cells via Mediating Platelet‐Derived Growth Factor Receptor β Degradation
by: Yong‐Qing Dou, et al.
Published: (2025-05-01)

Teclistamab <i>versus</i> B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis
by: Junmin Song, et al.
Published: (2025-04-01)

Genetics in Dentistry: A Review of Advances and Implications
by: Jyotsana Singh, et al.
Published: (2025-05-01)

Safety and efficacy of BCMA CAR-T <i>vs.</i> bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis
by: Hayley Vandenboom, et al.
Published: (2025-08-01)

O Naprzemienności Ruchu przy Pewnym Tłumieniu Nieliniowym
by: Z. Osiński
Published: (1960-03-01)

From Consultation to Coproduction: A Comparison of Participation in Poverty Research
by: Agathe Osinski
Published: (2021-02-01)

From Complement-dependent Cytotoxicity to Virtual Crossmatch: The Path Travelled in Renal Transplant Immunology
by: S. Sabarinath, et al.
Published: (2025-04-01)